These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7449976)

  • 1. [Characteristics of lipoprotein metabolic disorders during treatment with oral contraceptives].
    Titov VN; Sanfirova VM; Khodakova TD
    Farmakol Toksikol; 1980; 43(3):345-8. PubMed ID: 7449976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolism of lipoproteins in rats treated with ethinyl estradiol].
    Tvorogova MG; Titov VN
    Vopr Med Khim; 1986; 32(1):42-9. PubMed ID: 3953011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of ethinyl-estradiol on the biosynthesis and esterification of fatty acids in the rat liver].
    Sanfirova VM; Timov VN; Rulin VA
    Vopr Med Khim; 1984; 30(2):81-7. PubMed ID: 6146227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of ethynyl estradiol and estradiol dipropionate on the esterification of saturated and unsaturated fatty acids in the rat liver].
    Sanfirova VM; Titov VN; Gromadova M
    Vopr Med Khim; 1987; 33(2):77-83. PubMed ID: 3604148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Benign liver-cell-tumors and oral contraceptives (author's transl)].
    Fabian W; Höer PW; März E; Blum U
    Med Klin; 1979 Apr; 74(17):662-6. PubMed ID: 440191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters.
    Winkler UH; Sudik R
    Contraception; 2009 Jan; 79(1):15-23. PubMed ID: 19041436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Budd-Chiari syndrome, liver cell adenoma and polycythemia following contraceptives].
    Pees HW; Uhl UJ
    Med Welt; 1983 Jun; 34(25-26):722-5. PubMed ID: 6310314
    [No Abstract]   [Full Text] [Related]  

  • 8. A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.
    Skouby SO; Endrikat J; Düsterberg B; Schmidt W; Gerlinger C; Wessel J; Goldstein H; Jespersen J
    Contraception; 2005 Feb; 71(2):111-7. PubMed ID: 15707560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oral contraceptives: 30 vs 20 micrograms of ethinyl estradiol (EE)].
    Urdinola J
    Adv Contracept; 1994 Jul; 10 Suppl 1():41-9. PubMed ID: 7839871
    [No Abstract]   [Full Text] [Related]  

  • 11. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
    Stanely Mainzen Prince P; Kannan NK
    J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contraception and endometrial carcinoma (author's transl)].
    De Brux J
    Contracept Fertil Sex (Paris); 1976 Sep; 4(5):339-42. PubMed ID: 791719
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lipids, lipoproteins, arterial accidents and oral contraceptives].
    Bakir R; Hilliquin P
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):81-7. PubMed ID: 12341243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oral contraception and cerebrovascular accidents].
    Nick J; Bakouche P; Beaumont V; Vedrenne C
    Bull Acad Natl Med; 1981 Jun; 165(6):723-30. PubMed ID: 7034891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lead-induced phospholipidosis and cholesterogenesis in rat tissues.
    Ademuyiwa O; Agarwal R; Chandra R; Behari JR
    Chem Biol Interact; 2009 May; 179(2-3):314-20. PubMed ID: 19056365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diabetes regulation and oral contraceptives. Lipoporotein metabolism in women with insulin dependent diabetes mellitus using oral contraceptives].
    Petersen KR; Skouby SO; Jepsen PV; Haaber AB
    Ugeskr Laeger; 1996 Apr; 158(17):2388-92. PubMed ID: 8685993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral contraceptives, hyperlipoproteinemia and ischemic heart disease].
    Titov VN; Zhemerikina EV; Shcherbakova IA; Gerasimova EN; Khomasuridze AG
    Ter Arkh; 1978; 50(12):22-8. PubMed ID: 217116
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of effect of tenofovir disoproxil fumarate on pharmacokinetics of hormonal contraceptives.
    Kearney BP; Mathias A
    Pharmacotherapy; 2009 Aug; 29(8):924-9. PubMed ID: 19637945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperlipoproteinemia of aminonucleoside-induced nephrotic syndrome--modulation by glucocorticoids and triiodothyronine.
    Shafrir E
    Isr J Med Sci; 1996 Jun; 32(6):390-7. PubMed ID: 8682644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of contraceptive steroids on plasma lipoprotein metabolism in female rats (II).
    Köse K; Doğan P; Ozesmi C
    Biochem Mol Biol Int; 1993 Jun; 30(2):245-52. PubMed ID: 8364406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.